A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34)

Haematologica

Volumn 94, Issue 10, 2009, Pages 1469-1471

  Mustjoki, Satu ^a   Hernesniemi, Sari ^a   Rauhala, Auvo ^b   Kähkönen, Marketta ^c   Almqvist, Anders ^b   Lundán, Tuija ^a,d   Porkka, Kimmo ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b VAASA CENTRAL HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; DASATINIB; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; CANCER REGRESSION; CASE REPORT; CHROMOSOME 1; CHROMOSOME 9; CHROMOSOME ANALYSIS; DRUG MEGADOSE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; LETTER; MALE;

ADULT; AMINO ACID SEQUENCE; GENE FUSION; GENES, ABL; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MOLECULAR SEQUENCE DATA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELLS, B-LYMPHOID; PYRIMIDINES; THIAZOLES; TRANSLOCATION, GENETIC;

EID: 70349646617     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.008094     Document Type: Letter

References (10)

1. Ottmann O, Dombret H, Martinelli G, Simonsson B, Guilhot F, Larson RA, et al. Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study. Blood 2007;110:2309-2315 (Pubitemid 47523149)
2. De Braekeleer E, Douet-Guilbert N, Le Bris MJ, Berthou C, Morel F, De Braekeleer M. A new partner gene fused to ABL1 in a t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia. Leukemia 2007;21:2220-2221 (Pubitemid 47423823)
3. Van Limbergen H, Beverloo HB, van Drunen E, Janssens A, Hahlen K, Poppe B, et al. Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia. Genes Chromosomes Cancer 2001;30:274-282 (Pubitemid 32126204)
4. Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R, et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 2004;36:1084-1089 (Pubitemid 41184470)
5. De Keersmaecker K, Graux C, Odero MD, Mentens N, Somers R, Maertens J, et al. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32). Blood 2005;105:4849-4852 (Pubitemid 40807313)
6. Hidalgo-Curtis C, Chase A, Drachenberg M, Roberts MW, Finkelstein JZ, Mould S, et al. The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1. Genes Chromosomes Cancer 2008;47:379-385
7. Roumiantsev S, de Aos IE, Varticovski L, Ilaria RL, Van Etten RA. The src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase. Blood 2001;97:4-13. (Pubitemid 32061237)
8. Eyers CE, McNeill H, Knebel A, Morrice N, Arthur SJ, Cuenda A, et al. The phosphorylation of CapZ-interacting protein (CapZIP) by stress-activated protein kinases triggers its dissociation from CapZ. Biochemical J 2005;389:127-135 (Pubitemid 40978015)
9. Deenik W, Beverloo HB, van der Poel-van de Luytgaarde SC, Wattel MM, van Esser JW, Valk PJ, et al. Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia. Leukemia 2009;23: 627-629
10. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARS. 2008.